Sunitinib deregulates tumor adaptation to hypoxia by inhibiting HIF-1alpha synthesis in HT-29 colon cancer cells. [electronic resource]
- Biochemical and biophysical research communications Jul 2010
- 205-11 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1090-2104
10.1016/j.bbrc.2010.06.060 doi
Antineoplastic Agents--pharmacology Cell Hypoxia--drug effects HT29 Cells Humans Hypoxia-Inducible Factor 1, alpha Subunit--antagonists & inhibitors Indoles--pharmacology Neoplasms--metabolism Protein Biosynthesis Protein Kinase Inhibitors--pharmacology Pyrroles--pharmacology Signal Transduction Sunitinib